ICMR Set To Team Up With
Domestic Manufacturers To Accelerate Indigenous Production Of Medical Devices &
In a bid to reduce India’s dependency on
imports for its medical device needs, the Indian Council of Medical Research (ICMR)
is set to join hands with domestic manufacturers to accelerate development of
medical devices and diagnostic products and their scale-up, thus catalyzing
their commercialization for public use.
The apex medical research body on February
21, 2022 invited Expression of Interest (EOI) from experienced Indian companies
for collaboration in this regard. The last date for submitting EOI is March 15,
The Indian medical device market is currently
valued at USD 11.2 billion and is experiencing a growth rate of 15 per cent CAGR
and is poised to be USD 50 billion by 2025. India is dependent on imports for
its medical device needs with about 80 per cent of medical devices being
imported. In view of the huge import, dependency and long technology development
cycle of medical devices, there is an urgent need for providing holistic support
across the medical device development and commercialization cycle including R&D,
scale-up, validation, regulatory compliance, market access etc.
To cater to the above challenges, ICMR has
established Medical Device and Diagnostics Mission Secretariat (MDMS) at its
headquarters with a vision to support and catalyze research, development and
indigenous manufacturing of cost-effective medical devices to strengthen health
care sector in India and reduce import dependency through a Mission mode
consortia approach. MDMS will incentivize and motivate local manufacturing in
India and provide holistic support to the technologies/ products nearing
The priority medical device and diagnostic
products significantly contributing to imports were identified by ICMR under the
Product Ignition and Development Enabler (mPRiDE) program of MDMS.
Companies which have extensive experience and
demonstrated capabilities in developing dialysis machines, ultrasonography,
echocardiogram machines and extracorporeal membrane oxygenation (ECMO) machines
are encouraged to put-up their application under this program. The medical
device technologies at an advanced stage of development will be supported
through this program. Subject to the terms and conditions of an agreement,
ICMR-MDMS shall support indigenous development, scale-up and pilots of
Make-in-India manufacturing of critical medical devices and diagnostic products.
Based on the recommendations of the Expert
Committee the applications for manufacturing Make-In-India products in dialysis
machines, ultrasonography, echocardiogram machine and extracorporeal membrane
oxygenation (ECMO) machines categories will be duly considered for extending
The funding support under the present scheme
is in the form of grant-in-aid. Extent of funding is up to Rs 1.5 crore based on
Centre Nod For Medical
Device Park In Solan
Shimla: Union government has approved the detailed project report of medical
device park proposed to be developed at Nalagarh in Solan district where land
measuring 265 hectares has been identified. The estimated cost of the park is Rs
350 crore of which Rs 100 crore financial assistance would be provided by the
Chief minister Jai Ram Thakur said the project will be completed by April 2024.
He said on completion, this park would provide employment to 10,000 people with
the investment of Rs 5,000 crore.
The central government in September 2021 had given “inprinciple” approval to
set-up the park in Himachal Pradesh, Tamil Nadu, Madhya Pradesh and Uttar
Pradesh. Centre has identified the industry as a sunrise sector with great
potential for diversification and employment generation. Recognising the need
for higher levels of investments for the creation of proper infrastructure in
the sector, the department of pharmaceuticals has notified the scheme for
promotion of medical device parks.